(Total Views: 361)
Posted On: 12/13/2019 11:45:42 AM
Post# of 72448
Looking good as things come together. Looking forward to seeing the Locust Walk deal soon as well.
I'm curious if IPIX would qualify for something like this...
This is New Jersey and I don't know if Mass. has something similar or not...
...State of New Jersey of its available unused net operating losses (NOLs) and R&D tax credits that can be sold under the New Jersey Economic Development Authority's (NJEDA) Technology Business Tax Certificate Transfer (NOL) program.
The NOL program, administered by the NJEDA, enables approved biotechnology companies to sell their unused NOLs and R&D tax credits to unaffiliated, profitable corporate taxpayers in the State of New Jersey. This allows biotechnology companies with NOLs to turn their losses into credits and into cash proceeds to immediately realize much of the future value of these tax benefits, up to a maximum lifetime benefit of $15 million per business. For more details on the funding for this year's NOL program, please visit www.njeda.com.
Part of my trading strategy includes looking for beat down biotechs, this is one of them...
https://finance.yahoo.com/news/scynexis-stren...00065.html
I'm curious if IPIX would qualify for something like this...
This is New Jersey and I don't know if Mass. has something similar or not...
...State of New Jersey of its available unused net operating losses (NOLs) and R&D tax credits that can be sold under the New Jersey Economic Development Authority's (NJEDA) Technology Business Tax Certificate Transfer (NOL) program.
The NOL program, administered by the NJEDA, enables approved biotechnology companies to sell their unused NOLs and R&D tax credits to unaffiliated, profitable corporate taxpayers in the State of New Jersey. This allows biotechnology companies with NOLs to turn their losses into credits and into cash proceeds to immediately realize much of the future value of these tax benefits, up to a maximum lifetime benefit of $15 million per business. For more details on the funding for this year's NOL program, please visit www.njeda.com.
Part of my trading strategy includes looking for beat down biotechs, this is one of them...
https://finance.yahoo.com/news/scynexis-stren...00065.html
(3)
(0)
